RIPK1 and glioma: We observed an upregulation of programed necrosis-related proteins MLKL/RIPK3 and a concomitant downregulation of RIPK1 expression in glioma cell lines U251, U87, A172, and T98G, as well as in an in vivo subcutaneous tumor model, following Shikonin interventions.